Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities
Abstract The role of Interleukin-40 (IL-40) in rheumatoid arthritis (RA) is not well understood, and this study was designed to explore serum IL-40 levels in RA patients to assess its potential as a disease biomarker. In this research, serum IL-40 levels were determined using enzyme-linked immunosor...
Saved in:
| Main Authors: | Wei Wang, Juan Zhao, Siyu Wu, Jinfang Fu, Yunli Zhang, Wanchan Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-80104-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Therapy for Rheumatoid Arthritis in the New Era
by: WANG Jun, et al.
Published: (2025-01-01) -
Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014-07-01) -
Effects of IL-6, JAK, TNF inhibitors, and CTLA4-Ig on knee symptoms in patients with rheumatoid arthritis
by: Koichi Murata, et al.
Published: (2024-07-01) -
Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An extension study
by: Małgorzata Wisłowska
Published: (2024-11-01) -
Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis
by: Patricia Ruiz-Limón, et al.
Published: (2025-01-01)